Literature DB >> 8029023

Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells.

P G McCaffrey1, P K Kim, V E Valge-Archer, R Sen, A Rao.   

Abstract

We have investigated the characteristics of IL2R alpha gene induction in untransformed murine T cells. Induction of IL2R alpha mRNA by TCR/CD3 ligands in a murine T cell clone and in short-term splenic T cell cultures was inhibited by protein synthesis inhibitors and by CsA. This result was contrary to previous observations in JURKAT T leukemia cells and human peripheral blood T cells, suggesting a difference in the mechanisms of IL2R alpha gene induction in these different cell types. The CsA sensitivity of IL2R alpha mRNA induction represented a direct effect on the TCR/CD3 response, and was not due to CsA-sensitive release of the lymphokines IL2 or tumour necrosis factor alpha (TNF alpha) and consequent lymphokine-mediated induction of IL2R alpha mRNA. The NF-kappa B site of the IL2R alpha promoter was essential for gene induction through the TCR/CD3 complex, and the induction of reporter plasmids containing multimers of this site was significantly inhibited by CsA. Northern blotting analysis indicated that while the p65 subunit of NF-kappa B was constitutively expressed and not appreciably induced upon T cell activation, mRNA for the p105 precursor of p50 NF-kappa B was induced in response to TCR/CD3 stimulation and this induction was sensitive to CsA. Electrophoretic mobility shift assays and antiserum against the p50 subunit of NF-kappa B indicated that p50 was a component of the inducible nuclear complex that bound to the IL2R alpha kappa B site. Appearance of the kB-binding proteins was insensitive to CsA at early times after activation (approximately 15 min), but was partially sensitive to CsA at later times. Based on these results, we propose that the NF-kappa B site of the IL2R alpha promoter mediates at least part of the CsA sensitivity of IL2R alpha gene induction in untransformed T cells, possibly because de novo synthesis of p105 NF-kappa B is required for sustained IL2R alpha expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8029023      PMCID: PMC308132          DOI: 10.1093/nar/22.11.2134

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  56 in total

1.  A second sequence element located 3' to the NF-kappa B-binding site regulates IL-2 receptor-alpha gene induction.

Authors:  J L Pomerantz; F Mauxion; M Yoshida; W C Greene; R Sen
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

Review 2.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Induction of interleukin-2 receptor-alpha gene expression is regulated by post-translational activation of kappa B specific DNA binding proteins.

Authors:  E Böhnlein; D W Ballard; H Bogerd; N J Peffer; J W Lowenthal; W C Greene
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

4.  The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat.

Authors:  M R Smith; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Authors:  M J Tocci; D A Matkovich; K A Collier; P Kwok; F Dumont; S Lin; S Degudicibus; J J Siekierka; J Chin; N I Hutchinson
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

6.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

7.  Mutants in signal transduction through the T-cell antigen receptor.

Authors:  J G Wong; A Rao
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

8.  Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation.

Authors:  E A Emmel; C L Verweij; D B Durand; K M Higgins; E Lacy; G R Crabtree
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

9.  The same target sequences are differentially important for activation of the interleukin 2 receptor alpha-chain gene in two distinct T-cell lines.

Authors:  M B Toledano; D G Roman; N F Halden; B B Lin; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer.

Authors:  C Randak; T Brabletz; M Hergenröther; I Sobotta; E Serfling
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

View more
  6 in total

Review 1.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

2.  Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.

Authors:  K Kalli; C Huntoon; M Bell; D J McKean
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  Transcriptional control of rapid recall by memory CD4 T cells.

Authors:  Wendy Lai; Minjun Yu; Min-Nung Huang; Francesca Okoye; Achsah D Keegan; Donna L Farber
Journal:  J Immunol       Date:  2011-06-03       Impact factor: 5.422

4.  FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells.

Authors:  L Venkataraman; S J Burakoff; R Sen
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

5.  Follicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression.

Authors:  Martin Vaeth; Gerd Müller; Dennis Stauss; Lena Dietz; Stefan Klein-Hessling; Edgar Serfling; Martin Lipp; Ingolf Berberich; Friederike Berberich-Siebelt
Journal:  J Exp Med       Date:  2014-03-03       Impact factor: 14.307

Review 6.  Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches.

Authors:  Mi Hee Park; Jin Tae Hong
Journal:  Cells       Date:  2016-03-29       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.